open access
Interstitial lung disease associated with surfactant protein B and C deficiencies
open access
Abstract
Abstract
Keywords
interstitial lung disease; surfactant; children


Title
Interstitial lung disease associated with surfactant protein B and C deficiencies
Journal
Advances in Respiratory Medicine
Issue
Article type
Review paper
Pages
224-228
Published online
2010-05-11
Bibliographic record
Pneumonol Alergol Pol 2010;78(3):224-228.
Keywords
interstitial lung disease
surfactant
children
Authors
Aleksandra Szczawińska-Popłonyk
Anna Bręborowicz
Renata Langfort


- Canakis AM, Cutz E, Manson D, et al. Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease. Am J Respir Crit Care Med. 2002; 165(11): 1557–1565.
- Deterding RR, Fan LL, Morton R, et al. Persistent tachypnea of infancy (PTI)--a new entity. Pediatr Pulmonol. 2001; Suppl 23: 72–73.
- Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol. 2004; 66: 601–623.
- Lyra PP, Diniz EM. The importance of surfactant on the development of neonatal pulmonary diseases. Clinics (Sao Paulo). 2007; 62(2): 181–190.
- McFetridge L, McMorrow A, Morrison PJ, et al. Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD). Ulster Med J. 2009; 78(1): 7–9.
- Hartl D, Griese M. Interstitial lung disease in children -- genetic background and associated phenotypes. Respir Res. 2005; 6: 32–48.
- Tredano M, Blic JD, Griese M, et al. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis]. Ann Biol Clin (Paris). 2001; 59(2): 131–148.
- Tredano M, Griese M, Brasch F, et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A. 2004; 126A(1): 18–26.
- Whitsett JA, Wert SE, Weaver TE, et al. Genetic disorders of surfactant homeostasis. Biol Neonate. 2005; 87(4): 240–242.
- Yurdakök M. Inherited disorders of neonatal lung diseases. Turk J Pediatr. 2004; 46(2): 105–114.
- Klein JM, Thompson MW, Snyder JM, et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr. 1998; 132(2): 244–248.
- Dunbar AE, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res. 2000; 48(3): 275–282.
- Makri V, Hospes B, Stoll-Becker S, et al. Polymorphisms of surfactant protein B encoding gene: modifiers of the course of neonatal respiratory distress syndrome? Eur J Pediatr. 2002; 161(11): 604–608.
- Haataja R, Hallman M. Surfactant proteins as genetic determinants of multifactorial pulmonary diseases. Ann Med. 2002; 34(5): 324–333.
- Percopo S, Cameron HS, Nogee LM, et al. Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation. Eur Respir J. 2004; 24(6): 1072–1073.
- Lawson WE, Grant SW, Ambrosini V, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax. 2004; 59(11): 977–980.
- Beers MF, Mulugeta S. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol. 2005; 67: 663–696.
- Augusto LA, Synguelakis M, Johansson J, et al. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect Immun. 2003; 71(1): 61–67.
- Whitsett JA, Wert SE, Weaver TE, et al. Genetic disorders of surfactant homeostasis. Biol Neonate. 2005; 87(4): 283–287.
- Park KS, Whitsett JA, Di Palma T, et al. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C. J Biol Chem. 2004; 279(17): 17384–17390.
- Matsuzaki Y, Besnard V, Clark JC, et al. STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells. Am J Respir Cell Mol Biol. 2008; 38(5): 551–558.
- Yoshida I, Ban N, Inagaki N. Expression of ABCA3, a causative gene for fatal surfactant deficiency, is up-regulated by glucocorticoids in lung alveolar type II cells. Biochem Biophys Res Commun. 2004; 323(2): 547–555.
- Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008; 63(4): 366–373.
- Bullard JE, Wert SE, Whitsett JA, et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med. 2005; 172(8): 1026–1031.
- Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res. 2007; 62(2): 176–179.
- Nogee L. Genetics of pediatric interstitial lung disease. Current Opinion in Pediatrics. 2006; 18(3): 287–292.
- Hamvas A, Cole FS, Nogee LM. Genetic disorders of surfactant proteins. Neonatology. 2007; 91(4): 311–317.
- Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009; 12(4): 253–274.
- Zhou J, You Y, Ryan AJ, et al. Upregulation of surfactant synthesis triggers ABCA1-mediated basolateral phospholipid efflux. J Lipid Res. 2004; 45(9): 1758–1767.
- Tredano M, Blic JD, Griese M, et al. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis]. Ann Biol Clin (Paris). 2001; 59(2): 131–148.